Connection

Christina Johnson to Combined Modality Therapy

Back to Details
This is a "connection" page, showing publications Christina Johnson has written about Combined Modality Therapy.
Christina Johnson
Connection Strength
0.029
Combined Modality Therapy
  1. The histone deacetylase inhibitors depsipeptide and MS-275, enhance TRAIL gene therapy of LNCaP prostate cancer cells without adverse effects in normal prostate epithelial cells. Cancer Gene Ther. 2007 Mar; 14(3):327-34.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.